Literature DB >> 27564982

Schnitzler syndrome: validation and applicability of diagnostic criteria in real-life patients.

L Gusdorf1, B Asli2, S Barbarot3, A Néel4, A Masseau4, X Puéchal5, J-E Gottenberg6, G Grateau7, C Blanchard-Delaunay8, R Rizzi9, F Lifermann10, X Kyndt11, F Aubin12, D Bessis13, T Boye14, S Gayet15, F Rongioletti16, E Sauleau17, J-P Fermand2, D Lipsker1.   

Abstract

BACKGROUND: Schnitzler syndrome is characterized by an urticarial rash, a monoclonal gammopathy, and clinical, histological, and biological signs of neutrophil-mediated inflammation. The aim of this study was to assess the applicability and validity of the existing diagnostic criteria in real-life patients.
METHODS: This multicentric study was conducted between 2009 and 2014 in 14 hospitals in which patients with Schnitzler syndrome or controls with related disorders were followed up. We compared the sensitivities and specificities and calculated the positive and negative predictive values of the Lipsker and of the Strasbourg criteria for the patients with Schnitzler syndrome and for the controls. We included 42 patients with Schnitzler syndrome, 12 with adult-onset Still's disease, 7 with cryopyrin-associated periodic disease, 9 with Waldenström disease, and 10 with chronic spontaneous urticaria.
RESULTS: All patients with Schnitzler syndrome met the Lipsker criteria. According to the Strasbourg criteria, 34 patients had definite Schnitzler syndrome, five had probable Schnitzler syndrome, and three did not meet the criteria. One control met the Lipsker criteria and had probable Schnitzler syndrome according to the Strasbourg criteria. Sensitivity and specificity of the Lipsker criteria were 100% and 97%, respectively. For the Strasbourg criteria, sensitivity for definite and probable diagnosis was 81% and 93%, respectively, with a corresponding specificity of 100% and 97%.
CONCLUSION: Diagnostic criteria currently in use to diagnose Schnitzler syndrome are reliable. More investigations must be done to attest their efficiency in patients with recent-onset manifestations.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Schnitzler syndrome; auto-inflammatory disease; diagnostic criteria; monoclonal gammopathy; neutrophilic urticarial dermatosis

Mesh:

Year:  2016        PMID: 27564982     DOI: 10.1111/all.13035

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  17 in total

Review 1.  Schnitzler Syndrome: a Review.

Authors:  L Gusdorf; D Lipsker
Journal:  Curr Rheumatol Rep       Date:  2017-08       Impact factor: 4.592

2.  [Schnitzler syndrome].

Authors:  F F Gellrich; C Günther
Journal:  Z Rheumatol       Date:  2019-02       Impact factor: 1.372

3.  [Schnitzler syndrome].

Authors:  F F Gellrich; C Günther
Journal:  Hautarzt       Date:  2018-09       Impact factor: 0.751

Review 4.  Urticaria and Angioedema: an Update on Classification and Pathogenesis.

Authors:  Susanne Radonjic-Hoesli; Kathrin Scherer Hofmeier; Sara Micaletto; Peter Schmid-Grendelmeier; Andreas Bircher; Dagmar Simon
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

Review 5.  Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases.

Authors:  Hideyuki Ujiie; David Rosmarin; Michael P Schön; Sonja Ständer; Katharina Boch; Martin Metz; Marcus Maurer; Diamant Thaci; Enno Schmidt; Connor Cole; Kyle T Amber; Dario Didona; Michael Hertl; Andreas Recke; Hanna Graßhoff; Alexander Hackel; Anja Schumann; Gabriela Riemekasten; Katja Bieber; Gant Sprow; Joshua Dan; Detlef Zillikens; Tanya Sezin; Angela M Christiano; Kerstin Wolk; Robert Sabat; Khalaf Kridin; Victoria P Werth; Ralf J Ludwig
Journal:  Front Med (Lausanne)       Date:  2022-06-09

6.  Monoclonal gammopathies of clinical significance.

Authors:  Angela Dispenzieri
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

Review 7.  Kidney involvement in the Schnitzler syndrome, a rare disease.

Authors:  Carlo Basile; Luigi Rossi; Francesco Casucci; Annalisa Teutonico; Pasquale Libutti; Piero Lisi; Carlo Lomonte; Raffaele Manna
Journal:  Clin Kidney J       Date:  2017-07-26

Review 8.  Efficacy of interleukin-1 blockade in Schnitzler's syndrome without detectable monoclonal gammopathy: a case-based review.

Authors:  Riccardo Bixio; Maurizio Rossini; Alessandro Giollo
Journal:  Clin Rheumatol       Date:  2020-11-11       Impact factor: 2.980

9.  The combined prevalence of classified rare rheumatic diseases is almost double that of ankylosing spondylitis.

Authors:  Judith Leyens; Tim Th A Bender; Martin Mücke; Christiane Stieber; Dmitrij Kravchenko; Christian Dernbach; Matthias F Seidel
Journal:  Orphanet J Rare Dis       Date:  2021-07-22       Impact factor: 4.123

10.  Schnitzler's Syndrome: A Diagnostic Consideration in Evaluating the Constellation of Monoclonal Gammopathy and Chronic Urticaria.

Authors:  Jyothika Mamadgi; Laila Babar; Rama Bhagavatula; Santhosh Sadashiv; Kossivi Dantey; Mariya Apostolova
Journal:  J Hematol       Date:  2021-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.